echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > China's new crown vaccine may be able to effectively resist the SARS-CoV-2 mutant strain

    China's new crown vaccine may be able to effectively resist the SARS-CoV-2 mutant strain

    • Last Update: 2021-01-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    January 7, 2021 // -- This week, medical staff from Shanghai, China, were vaccinated against COVID-19, which vaccine manufacturers say is equally effective against the virus that is currently mutated.
    china is now rushing to vaccinate millions of people against the new crown before the Spring Festival.
    Chinese pharmaceutical giant China Pharmaceutical Holdings last week obtained "conditional" approval for its vaccine candidate, and manufacturers said they were confident the vaccine would be effective despite the rapid spread of a new mutation, the SARS-CoV-2 virus.
    Photo Source: Yang Xiaoming, chairman of CC0 Public Domain China Biotechnology Co., Ltd., told CCTV on Monday that the current mutation in SARS-CoV-2 does not invalidate the vaccine, and that according to state media, the new crown vaccination is now being carried out in key populations across the country, such as community workers, logistics or food practitioners;
    Global Times, citing unnamed industry observers, said the small percentage of older volunteers in clinical trials of the new vaccine explains the need to be careful about getting the vaccine in older people.
    China National Pharmaceutical Holdings said the effectiveness of the new crown vaccine can reach 79%, requiring two injections, each 2-4 weeks apart, Yang Xiaoming told CCTV, the dose of the new crown vaccine has a number, like an identity card.
    This ID may help us find the source of the vaccine from raw materials and its past manufacturing processes; in February, China is about to welcome the world's largest migration, hundreds of millions of people will be reunited with their families to celebrate the Lunar New Year, and 73,000 people, including bus drivers and community workers, have been vaccinated against the new crown in Beijing, China's capital.
    china has largely controlled the popularity and spread of COVID-19 through strict blockades and travel restrictions.
    believe that the entry and outbreak of the outbreak will be more effectively controlled through the widespread vaccination of the late-stage new crown vaccine.
    () Original source: As China vaccinees, makers say jab works againstst mutationsChinese medics in Shanghai were were given COVID-19 inoculations this week, as vaccines makers insisted on their jab was was effectivest current virus mutations. China is racing to vaccinate millions ahead of the country's Spring Festival travel rush. Pharma giant Sinopharm was given "conditional" approval for its vaccine candidate last week, and makers said they were confident the vaccine was effective despite a new variant strain spreading rapidly......
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.